Mapping alveolar binding sites in vivo using phage peptide libraries

M Wu1, R Pasula, P A Smith

  • 1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Gene Therapy
|August 6, 2003
PubMed

Insights

Researchers developed a new method using phage display to find peptides that specifically target lung epithelial cells. This technique enhances precision for lung tissue targeting and molecular analysis.

Area of Science:

  • Biotechnology
  • Pulmonary Medicine
  • Molecular Biology

Background:

  • Targeting lung tissue specifically is challenging due to the absence of identified cell-surface receptors on lung cells.
  • Current methods for lung tissue targeting often lack selectivity, leading to off-target effects.

Purpose of the Study:

  • To identify peptides that selectively bind to lung epithelial cells using in vivo phage display.
  • To overcome the limitations of nonselective lung tissue targeting.

Main Methods:

  • In vivo phage display was performed by intratracheal instillation of phage libraries into the lung.
  • 143 individual phage clones were isolated and screened for enhanced binding in vitro and in vivo.
  • Selected peptides were synthesized and tested for selective binding to lung epithelial cells and type II alveolar cells.

Main Results:

  • Three phage clones demonstrated enhanced binding to lung tissue both in vitro and in vivo.
  • Synthesized peptides showed selective binding to lung epithelial cells compared to a control peptide.
  • The identified peptides specifically bound to freshly isolated type II alveolar epithelial cells.

Conclusions:

  • The airway phage display approach is effective for identifying lung-specific targeting peptides.
  • This method can be utilized to analyze molecular diversity within the lower respiratory tract.
  • The identified peptides hold potential for improving targeted drug delivery to lung tissues.

Related Concept Videos